We’ve Got You Covered

May is Melanoma and Skin Cancer Awareness Month

Summer is right around the corner and it’s the perfect time to talk about skin cancer. We’ve got you covered as your pharmacy partner with many treatment options, expert clinical support, and prevention information.

Skin cancer is the most common cancer in the United States for men and women. Some people are at a higher risk than others, but anyone can get it.

Three Main Types

  • Basal cell carcinoma – As the most common type of skin cancer, these cancers start in the basal cell skin layer, which is the lower part of the epidermis, and tend to grow slowly.
  • Squamous cell carcinoma – These cancers start in the flat cells in the upper (outer) part of the epidermis and are less common than basal cell cancers.
  • Melanoma – Much less common and develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control.1

Lower Your Risk

There is no sure way to prevent skin cancer. Some risk factors such as your age, race, and family history can’t be controlled. But there are things you can do to lower your risk of melanoma and other skin cancers2:

  • Stay in the shade.
  • Wear clothing that covers your arms and legs
  • Wear a hat with a wide brim to shade your face, head, ears, and neck.
  • Wear sunglasses that wrap around and block both UVA and UVB rays.
  • Use a broad-spectrum sunscreen with a sun protection factor (SPF) of 15 or higher.
  • Avoid tanning beds.

Why Onco360?

Rx Ordering Made Easy

Limited Distribution Oncology Medications


Oncomed Dba Onco360 or
NPI# 1679618151

VONJO™ (pacritinib) for Myelofibrosis



Order Forms

Helpful Resources

If you would like to read further about skin cancer or prevention, here are some recommended resources:




1 https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/about/what-is-basal-and-squamous-cell.html

2 https://www.cdc.gov/cancer/skin/basic_info/sun-safety.htm#:~:text=You%20can%20reduce%20your%20risk,you’re%20in%20the%20shade.

* Third-party survey data provided by MMIT for Independent Specialty Pharmacies (Oncology). Report dates Q4 2021 and Q3 and Q4 2021